Publication | Closed Access

1,1′-Xylyl bis-1,4,8,11-tetraaza cyclotetradecane: A new potential copper chelator agent for neuroprotection in Alzheimer’s disease. Its comparative effects with clioquinol on rat brain copper distribution

Medicinal ChemistryNeurodegenerative DiseasesAlzheimer's Disease1,1′-Xylyl Bis-1,4,8,11-tetraaza CyclotetradecaneMedicineNeuropharmacologyComparative EffectsNeuroprotectionNeuroscienceNeurologyPharmacologyNeurochemistry